SYNLOGIC, INC. Debt Securities, Available-for-sale, Unrealized Loss Position
SYNLOGIC, INC. (SYBX) had Debt Securities, Available-for-sale, Unrealized Loss Position of $1.50 million as of 2024-03-31, per its 10-Q filed 2024-05-14.
Financial Statements › Notes › Debt and Equity Securities
us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition · last filed 2025-03-06
- 2024-03-31: Debt Securities, Available-for-sale, Unrealized Loss Position $1.50M.
- 2023-12-31: Debt Securities, Available-for-sale, Unrealized Loss Position $5.40M.
- 2023-03-31: Debt Securities, Available-for-sale, Unrealized Loss Position $17.90M.
- 2022-12-31: Debt Securities, Available-for-sale, Unrealized Loss Position $36.60M.
| Period end | Debt Securities, Available-for-sale, Unrealized Loss Position |
|---|---|
| 2024-03-31 | $1.50M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $5.40M 10-K · filed 2025-03-06 |
| 2023-03-31 | $17.90M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $36.60M 10-K · filed 2024-03-19 |
| 2022-09-30 | $76.00M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $75.90M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $99.70M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $72.20M 10-K · filed 2023-03-29 |
| 2021-09-30 | $11.40M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $15.50M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $28.80M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $20.10M 10-K · filed 2022-03-17 |
| 2020-09-30 | $10.00M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $14.00M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $25.70M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $24.80M 10-K · filed 2021-03-25 |
| 2019-09-30 | $9.50M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $46.30M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $35.60M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $96.50M 10-K · filed 2020-03-12 |
| 2018-09-30 | $94.00M 10-Q · filed 2018-11-13 |
| 2017-12-31 | $19.30M 10-K · filed 2019-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |